These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27599027)

  • 1. Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets.
    Zhang F; Meng F; Wang ZY; Na W
    Drug Dev Ind Pharm; 2017 Feb; 43(2):190-203. PubMed ID: 27599027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpolymer Complexation Between Polyox and Carbopol, and Its Effect on Drug Release From Matrix Tablets.
    Zhang F; Lubach J; Na W; Momin S
    J Pharm Sci; 2016 Aug; 105(8):2386-96. PubMed ID: 27353208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties and mechanisms of drug release from matrix tablets containing poly(ethylene oxide) and poly(acrylic acid) as release retardants.
    Zhang F; Meng F; Lubach J; Koleng J; Watson NA
    Eur J Pharm Biopharm; 2016 Aug; 105():97-105. PubMed ID: 27260202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of an extended-release matrix tablet using chitosan/Carbopol interpolymer complex.
    Park SH; Chun MK; Choi HK
    Int J Pharm; 2008 Jan; 347(1-2):39-44. PubMed ID: 17662544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of Carbopol/chitosan interpolymer complex as a controlled release tablet matrix; effect of complex formation medium on drug release characteristics.
    Lee MH; Chun MK; Choi HK
    Arch Pharm Res; 2008 Jul; 31(7):932-7. PubMed ID: 18704338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets.
    Barreiro-Iglesias R; Bromberg L; Temchenko M; Hatton TA; Alvarez-Lorenzo C; Concheiro A
    Eur J Pharm Sci; 2005 Dec; 26(5):374-85. PubMed ID: 16165345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpolymer complexes of carbopol® 971 and poly(2-ethyl-2-oxazoline): Physicochemical studies of complexation and formulations for oral drug delivery.
    Moustafine RI; Viktorova AS; Khutoryanskiy VV
    Int J Pharm; 2019 Mar; 558():53-62. PubMed ID: 30634031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation and Evaluation of an in Situ Interpolymer Complex of Carbopol with Polyvinylpyrrolidone as a Matrix for Gastroretentive Tablets of Ranitidine Hydrochloride.
    Yusif RM; Abu Hashim II; Mohamed EA; El Rakhawy MM
    Chem Pharm Bull (Tokyo); 2016; 64(1):42-51. PubMed ID: 26726743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoadhesive drug carrier based on interpolymer complex of poly(vinyl pyrrolidone) and poly(acrylic acid) prepared by template polymerization.
    Chun MK; Cho CS; Choi HK
    J Control Release; 2002 Jun; 81(3):327-34. PubMed ID: 12044571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
    Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
    Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Starch/Carbopol spray-dried mixtures as excipients for oral sustained drug delivery.
    Pringels E; Ameye D; Vervaet C; Foreman P; Remon JP
    J Control Release; 2005 Apr; 103(3):635-41. PubMed ID: 15820410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
    Ofoefule SI; Chukwu A
    Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
    Wulff R; Leopold CS
    Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer.
    Ketjinda W; Sinchaipanid N; Limsuwan P; Leuenberger H; Mitrevej A
    AAPS PharmSciTech; 2011 Mar; 12(1):132-40. PubMed ID: 21181509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin-Kollidon VA64 Extrudates: A Mechanistic Study of pH-Dependent Controlled Release.
    Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
    Mol Pharm; 2016 Mar; 13(3):1166-75. PubMed ID: 26845251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pectin/anhydrous dibasic calcium phosphate matrix tablets for in vitro controlled release of water-soluble drug.
    Mamani PL; Ruiz-Caro R; Veiga MD
    Int J Pharm; 2015 Oct; 494(1):235-43. PubMed ID: 26276258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Inorganic Salt on Disintegration of Tablets with High Loading of Amorphous Solid Dispersion Containing Copovidone.
    Xi H; Ren J; Novak JM; Kemp E; Johnson G; Klinzing G; Johnson MA; Xu W
    Pharm Res; 2020 Mar; 37(4):70. PubMed ID: 32185516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
    Van Nguyen H; Nguyen VH; Lee BJ
    Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.